对于IBS的FODMAP饮食组教育,是否有性别差异的反应? 一个临床实践服务评估评估
1Division of Medicine, University College London, London, UK.
Nutrition and health
|March 17, 2025
概括
低FODMAP饮食 (LFD) 有效地减少了男性和女性的刺激性肠综合征 (IBS) 症状. 这项研究发现,在LFD干预后,症状改善方面没有明显的性别差异.
科学领域:
- 胃肠病学 胃肠病学
- 饮食干预 饮食干预
- 临床研究 临床研究
背景情况:
- 刺激性肠综合征 (IBS) 是一种常见的胃肠疾病.
- 低FODMAP饮食 (LFD) 是有效的IBS症状管理.
- 关于IBS患者对LFD的性别特异反应的数据有限.
研究的目的:
- 为了调查潜在的性别差异,在饮食师主导的IBS患者的LFD小组教育课程后,症状改善.
- 评估LFD干预在不同性别的有效性.
主要方法:
- 305名IBS患者 (79.7%女性) 参加了两次LFD小组教育课程.
- 结果包括IBS症状严重性得分 (IBS-SSS),全球症状问题 (GSQ),便频率/一致性以及个别的胃肠道症状.
- 统计分析比较了基线和随访数据在性别内和性别之间.
主要成果:
- 男性和女性患者均显示IBS-SSS得分显著降低,GSQ,便特征和个人胃肠道症状有所改善 (p <0.05).
- 性别之间没有观察到症状缓解程度的统计学上显著差异 (p > 0.05).
结论:
- 通过小组教育进行的LFD干预,为男性和女性IBS患者提供了可比的症状缓解.
- 性别似乎不是LFD在IBS症状管理中的有效性的一个重要因素.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
290
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
290
Drugs for Treatment of Diarrhea-Predominant IBS
133
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
133
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
103
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
103
Irritable Bowel Syndrome III: Medical and Nursing Management
133
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
133
Irritable Bowel Syndrome I: Introduction
213
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
213
Drugs for Treatment of Constipation-Predominant IBS
124
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
124


